Structures and Synthesis of Natural Antitumor/Carcinogenic Substances.
Structures and Synthesis of Natural Antitumor/Carcinogenic Substances.
批准号:
04403009
负责人:
YAMADA Kiyoyuki
金额:
$23.42万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (A)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1994
中文摘要
对天然抗肿瘤/致癌物质的结构和合成进行了研究.抗肿瘤物质。本文用核磁共振波谱分析法和有机合成法测定了从海兔黑尾海兔中分离出的抗肿瘤活性物质--黑尾海兔碱A的绝对立体结构。实现了对映体选择性全合成阿龙宁A。从海兔中分离出同源物阿曲洛宁B和C,并建立了它们的结构:通过比较阿曲洛宁A、B和C的细胞毒性,阐明了阿曲洛宁A中三甲基丝氨酸基团对细胞毒性的作用。细胞毒性物质。从海兔Dolabella auricularia新的细胞毒性物质,如多拉司他汀C,D,E,和doliculide分离,其结构随后被确定。这些细胞毒性物质的结构通过合成明确证实。Doliculide的大规模合成足以对其抗肿瘤活性进行评价.致癌物质。从蕨菜致癌物质Ptaquiloside中提取的最终致癌物与DNA发生反应,最终致癌物与DNA发生烷基化反应,随后发生DNA断裂,详细阐明了DNA断裂的分子机理。合成了天然终极致癌物的简单类似物,其DNA切割活性与天然终极致癌物相当。
英文摘要
Studies on the structures and synthesis of natural antitumor/carcinogenic substances have been made.1. Antitumor substances. Absolute stereostructure of aplyronine A,a potent antitumor substance isolated as a minute constituent of the sea hare Aplysia kurodai was determined by NMR spectral analysis any by organic synthetic method. The enantioselective total synthesis of aplyronine A was achieved. The congeners aplyronines B and C were isolated from the sea hare and their structures were established : the role of the trimethylserine group in aplyronine A with respect to the cytotoxicity was clarified by comparison of the cytotoxicity of aplyronine A,B,and C.2. Cytotoxic substances. From the sea hare Dolabella auricularia new cytotoxic substances such as dolastatins C,D,E,and doliculide were isolated, the structures of which were subsequently determined. The structures of these cytotoxic substances were confirmed by the synthesis unambiguously. Doliculide was synthesized on a large scale sufficient for the evaluation of its antitumor activity.3. Carcinogenic substances. The ultimate carcinogen derived from ptaquiloside, a potent bracken carcinogenic substance was allowed to react with DNA.Thus, the alkylation of DNA with the ultimate carcinogen took place and subsequently cleavage of DNA occurred : the molecular mechanism of DNA cleavage was clarified in details. The simple analogue of the natural ultimate carcinogen was synthesized, which was shown to have the DNA cleaving activity comparable to that of natural ultimate carcinogen.
期刊论文(25)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Hideo Kigoshi: "Total Synthesis of Aplyronine A,a Potent Antitumor Substance of Marine Origin." Journal of the American Chemical Society. 116. 7443-7444 (1994)
Hideo Kigoshi:“Aplyronine A 的全合成,一种海洋来源的有效抗肿瘤物质。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hiroyuki Ishiwata, Takayuki Nemoto, Makoto Ojika, and Kiyoyuki Yamada: "Total Synthesis of Doliculide, a Potent Cytotoxic Cyclodepsipetide from the Japanese Sea Hare Dolabella auricularia" The Journal of Organic Chemistry. Vol.59, No.17. 4710-4711 (1994)
Hiroyuki Ishiwata、Takayuki Nemoto、Makoto Ojika 和 Kiyoyuki Yamada:“多利库利特的全合成,一种来自日本海兔 Dolabella aurillaryia 的强效细胞毒性环缩肽”有机化学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Makoto Ojika: "Absolute Stereochemistry of Aplyronine A,a Potent Antitumor Substance of Marine Origin." Journal of the American Chemical Society. 116. 7441-7442 (1994)
Makoto Ojika:“Aplyronine A 的绝对立体化学,一种海洋来源的有效抗肿瘤物质。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kiyoyuki Yamada: "Aplyronine A,a Potent Antitumor Substance,and the Congeners Aplyronines B and C Isolated from the Sea--" Journal of the American Chemical Society. 115. 11020-11021 (1993)
Kiyoyuki Yamada:“Aplyronine A,一种有效的抗肿瘤物质,以及从海洋中分离出的同系物 Aplyronine B 和 C——”美国化学会杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hideo Kigoshi: "Total Synthesis of Aplyronine A, a Potent Antitumor Substance of Marine Origin." Journal of the American Chemical Society. 116. 7443-7444 (1994)
Hideo Kigoshi:“Aplyronine A 的全合成,一种来自海洋的有效抗肿瘤物质。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 24 条
Chemical Modification of Nucleic Acids and Related Substances with a Carcinogen Ptaquiloside.
-
批准号:62470029
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$5.12万
-
财政年份:1987
-
负责人:YAMADA Kiyoyuki
-
依托单位:
国内基金
海外基金
用识别EBV相关淋巴瘤抗原多肽的T细胞受体做转基因免疫治疗
-
批准号:81041002
-
项目类别:专项基金项目
-
资助金额:10.0万元
-
批准年份:2010
-
负责人:岑溪南
-
依托单位:
Endoglin基因修饰肿瘤/DC杂交细胞诱生靶向特异性抗人肺癌CTL疫苗的研究
-
批准号:30760248
-
项目类别:地区科学基金项目
-
资助金额:16.0万元
-
批准年份:2007
-
负责人:周源
-
依托单位: